Carrier_1987_J.Pharmacol.Exp.Ther_242_531

Reference

Title : Altered muscarinic receptor properties and function in the heart in diabetes - Carrier_1987_J.Pharmacol.Exp.Ther_242_531
Author(s) : Carrier GO , Aronstam RS
Ref : Journal of Pharmacology & Experimental Therapeutics , 242 :531 , 1987
Abstract :

The cardiac cholinergic system was studied in streptozotocin (STZ)-diabetic and age-matched control rats. STZ-diabetic rats (8-10 weeks) were supersensitive to the negative chronotropic effects of acetylcholine, carbamylcholine and bethanechol; inotropic responses to these muscarinic agonists were unaltered. This phenomenon was associated with a decrease in acetylcholinesterase activity but no change in the rate and extent of neuronal choline uptake. [3H]N-methylscopolamine bound to muscarinic receptors in atria from both groups of rats with the same high affinity. The density of [3H]N-methylscopolamine binding sites, however, was 34% lower in atria from STZ-diabetic rats. Agonist binding affinity was lower in diabetes; carbamylcholine had a lower affinity for both the high- and low-affinity receptors. These results indicate that cardiac cholinergic supersensitivity in right atria in diabetes occurs before the development of autonomic neuropathy insofar as neuronal [3H]choline uptake is unaltered at this stage of STZ diabetes. Changes in agonist binding conformation, without a concomitant change in antagonist binding affinity, suggest that supersensitivity of right atria to muscarinic agonist may be a consequence of altered coupling of muscarinic receptor to transduction mechanisms involved in chronotropism in diabetes.

PubMedSearch : Carrier_1987_J.Pharmacol.Exp.Ther_242_531
PubMedID: 2956413

Related information

Citations formats

Carrier GO, Aronstam RS (1987)
Altered muscarinic receptor properties and function in the heart in diabetes
Journal of Pharmacology & Experimental Therapeutics 242 :531

Carrier GO, Aronstam RS (1987)
Journal of Pharmacology & Experimental Therapeutics 242 :531